Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 6/20 | 0.46 |
| ▸ | MAOA | P21397 | 2/20 | 0.46 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.40 |
| ▸ | GPR119 | Q8TDV5 | 6/20 | 0.40 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.36 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | GLA | P06280 | 1/20 | 0.36 |
| ▸ | CA3 | P07451 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | CA4 | P22748 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL220638 | 1.00 | MAOB (0.46) | MAOBMAOACHRM2CHRM1CHRM3 | |
| SCHEMBL15304583 | 0.89 | SLC6A2 (0.48) | MAOBMAOACHRM2CHRM1CHRM3 | |
| SCHEMBL741083 | 0.89 | SLC6A2 (0.48) | MAOBMAOACHRM2CHRM1CHRM3 | |
| SCHEMBL741084 | 0.89 | SLC6A2 (0.48) | MAOBMAOACHRM2CHRM1CHRM3 | |
| SCHEMBL248697 | 0.88 | MAOB (0.46) | MAOBMAOACHRM2CHRM1CHRM3 | |
| SCHEMBL3183936 | 0.88 | MAOB (0.44) | MAOBMAOACHRM2CHRM1CHRM3 | |
| SCHEMBL3183943 | 0.88 | MAOB (0.44) | MAOBMAOACHRM2CHRM1CHRM3 | |
| SCHEMBL1091835 | 0.88 | MAOB (0.44) | MAOBMAOACHRM2CHRM1CHRM3 | |
| SCHEMBL1091288 | 0.88 | MAOB (0.44) | MAOBMAOACHRM2CHRM1CHRM3 | |
| SCHEMBL1091768 | 0.88 | MAOB (0.44) | MAOBMAOACHRM2CHRM1CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120004257-A1 | NOVEL COMPOUNDS | NEUROSEARCH A/S (DK) | 2012-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120004257-A1 | NOVEL COMPOUNDS | SLC18A2, SLC18A3, SLC6A2 | MAOB 6/4885MAOA 8/4885CHRM2 89/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.